Correlation of plasma hepatitis C virus RNA levels with serum alanine aminotransferase in non-A, non-B chronic liver disease. 1993

M Kurosaki, and N Enomoto, and C Sato, and N Sakamoto, and Y Hoshino, and H Haritani, and F Marumo
Second Department of Internal Medicine, Faculty of Medicine, Tokyo Medical and Dental University, Japan.

The relationship between plasma hepatitis C virus (HCV) RNA levels, antibody positivity, and hepatocellular damage were studied in 41 patients with non-A, non-B chronic liver disease. The patients were placed into two groups according to the plasma levels of HCV-RNA: plasma HCV-RNA level was estimated as high when detected by a one stage polymerase chain reaction (PCR) and as low when detectable only after a two stage PCR. Anti-HCV (first and second generation assays) and anti-GOR were also measured. The mean alanine aminotransferase (ALT) level of the high HCV-RNA group was 115 +/- 62 IU/l, whereas that of the low HCV-RNA group was 59 +/- 37 IU/l (P < 0.05). Patients with ALT levels above 100 IU/l had invariably a high level of HCV-RNA. There were no differences in clinical features in relation to the presence of anti-GOR or anti-HCV. Circulating HCV-RNA levels but not anti-HCV or anti-GOR antibodies correlated with hepatocellular damage.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D005260 Female Females
D006508 Hepatitis Antibodies Immunoglobulins raised by any form of viral hepatitis; some of these antibodies are used to diagnose the specific kind of hepatitis. Antibodies, Hepatitis
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000410 Alanine Transaminase An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC 2.6.1.2. Alanine Aminotransferase,Glutamic-Pyruvic Transaminase,SGPT,Alanine-2-Oxoglutarate Aminotransferase,Glutamic-Alanine Transaminase,Alanine 2 Oxoglutarate Aminotransferase,Aminotransferase, Alanine,Aminotransferase, Alanine-2-Oxoglutarate,Glutamic Alanine Transaminase,Glutamic Pyruvic Transaminase,Transaminase, Alanine,Transaminase, Glutamic-Alanine,Transaminase, Glutamic-Pyruvic
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA

Related Publications

M Kurosaki, and N Enomoto, and C Sato, and N Sakamoto, and Y Hoshino, and H Haritani, and F Marumo
October 2010, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP,
M Kurosaki, and N Enomoto, and C Sato, and N Sakamoto, and Y Hoshino, and H Haritani, and F Marumo
January 1994, Journal of gastroenterology and hepatology,
M Kurosaki, and N Enomoto, and C Sato, and N Sakamoto, and Y Hoshino, and H Haritani, and F Marumo
October 2014, Hepatology (Baltimore, Md.),
M Kurosaki, and N Enomoto, and C Sato, and N Sakamoto, and Y Hoshino, and H Haritani, and F Marumo
January 2010, Indian journal of pathology & microbiology,
M Kurosaki, and N Enomoto, and C Sato, and N Sakamoto, and Y Hoshino, and H Haritani, and F Marumo
January 2006, Journal of gastroenterology and hepatology,
M Kurosaki, and N Enomoto, and C Sato, and N Sakamoto, and Y Hoshino, and H Haritani, and F Marumo
January 2021, Frontiers in medicine,
M Kurosaki, and N Enomoto, and C Sato, and N Sakamoto, and Y Hoshino, and H Haritani, and F Marumo
August 2009, Hepatology (Baltimore, Md.),
M Kurosaki, and N Enomoto, and C Sato, and N Sakamoto, and Y Hoshino, and H Haritani, and F Marumo
September 1999, Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology,
M Kurosaki, and N Enomoto, and C Sato, and N Sakamoto, and Y Hoshino, and H Haritani, and F Marumo
February 1992, Gastroenterology,
M Kurosaki, and N Enomoto, and C Sato, and N Sakamoto, and Y Hoshino, and H Haritani, and F Marumo
July 2005, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology,
Copied contents to your clipboard!